Companies

Kymera Therapeutics, Inc. (KYMR) SEC filings

CIK 0001815442 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)39.2 M46.8 M
Net income (USD)-45.6 M-41.2 M
Diluted EPS (USD/shares)-3.69-2.87

Latest filings

FiledFormDescriptionPeriod
2026-10-01442026-10-01
2026-10-01144144
2026-09-08SCHEDULE 13G/ASCHEDULE 13G/A
2026-09-04442026-09-04
2026-09-04144144
2026-09-02144144
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-0510-Q10-Q2026-06-30
2026-08-058-K8-K items 2.02,9.012026-08-05
2026-07-27442026-07-27
2026-07-27332026-07-27
2026-07-278-K8-K items 5.02,7.01,9.012026-07-27
2026-07-07442026-07-07
2026-07-07144144
2026-07-02442026-06-30
2026-07-02442026-07-01
2026-07-02442026-07-01
2026-07-024/A4/A2026-06-26
2026-07-02144144
2026-07-01144144
2026-06-30442026-06-26
2026-06-30442026-06-26
2026-06-30144144
2026-06-29144144

Forms on file (last 1,000): 4 265, 144 118, 8-K 76, 3 28, SC 13G/A 23, 10-Q 18, SCHEDULE 13G/A 16, SC 13G 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=KYMR (0.002 USD), /gw/filings/filings?ticker=KYMR&form=8-K, /gw/filings/facts?ticker=KYMR&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange